Calibre 🇬🇧
London healthtech offering a health membership that combines clinicians, diagnostics and causal AI to build personalised health plans. Amino Collective led the round.
About Calibre
The main product is a proactive health membership that integrates personalized diagnostic testing, clinician expertise, and causal AI to provide a comprehensive understanding of individual health and actionable insights for improvement. The service utilizes a combination of lab tests, lifestyle tracking, and advanced diagnostics to create tailored health plans and monitor progress over time.
Calibre is a UK-based company founded in 2025, now around 10 people. It has raised $3.1M in disclosed funding. FundFinder classes it as AI & ML.
Founded by Alexander Weber (Founder & CEO; previously Gousto, N26; Startup Institute), Reinhold Innerhofer (Founder & Chief Medical Officer; previously Olympiazentrum Salzburg; Medical University of Vienna), Ben Levy (Founder & CTO; previously Byte9, CONVOY by MML; University of Oxford).
Its investors also appear on FundFinder's most-active lists for Pre-seed · AI (61 funds), Pre-seed · B2B (73 funds), Pre-seed · Generalist (71 funds).
Company facts from Harmonic and public filings; team backgrounds from public profiles. Refreshed weekly.
Pre-seed · £2.4M · Apr 2026
- Amino Collective — Amino Collective is a health and bio venture firm founded in 2020 by Manuel Grossmann. · cheques £200k+
- Cocoa Ventures — VCs turned angels, Cocoa invests angel checks and becomes the in-house VC for founders. · cheques £100k – £300k